Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Q4 2022 Results Conference Call March 3, 2023 8:30 AM ET

Company Participants

Mike Beaulieu - VP, IR & Corporate Communications

Rob Spignesi - President, CEO

Sean Wirtjes - CFO

Conference Call Participants

Dan Arias - Stifel

Tejas Savant - Morgan Stanley

Rachel Vatnsdal - JP Morgan

Stephanie Yan - Cowen

Operator

Good morning, and welcome to Rapid Micro Biosystems Fourth Quarter and Full Year 2022 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.

I would now like to turn the call over to Mike Beaulieu, Vice President of Investor Relations and Corporate Communications. Thank you. Please go ahead, sir.

Mike Beaulieu

Good morning and thank you for joining the Rapid Micro Biosystems fourth quarter and full year 2022 earnings call. Joining me on the call are Rob Spignesi, President and Chief Executive Officer; and Sean Wirtjes, Chief Financial Officer. Earlier today, we issued a press release announcing our fourth quarter and full year financial results. A copy of the release is available on the company’s website at rapidmicrobio.com under Investors in the News & Events section.

Before we begin, I’d like to remind you that many statements made during this call may be considered forward-looking statements within the meaning of federal securities laws, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that relate to expectations or predictions of future events, results or performance are forward-looking statements, including, but not limited to, statements relating to Rapid Micro’s financial condition, anticipated year-end cash balance, cash runway and future revenue and system placements, expectations for business development and growth, customer interest and adoption of the Growth Direct System, expectations for our new RMBNucleus Mold Alarm and the potential impact of macroeconomic uncertainty and coronavirus pandemic on Rapid Micro’s business.

Actual results may differ materially from those expressed or implied in the forward-looking statements due to a variety of factors. For a list and description of the risks and uncertainties associated with Rapid Micro’s business, please refer to the Risk Factors section of our Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 24, 2022, as such risk factors are updated in our subsequent filings with the SEC. We urge you to consider these factors and you should be aware that these statements should be considered estimates only and are not a guarantee of future performance.